American Society of Clinical Oncology

SHERPA: White

People

  1. Matasar
    Matasar
  2. Abdel-Wahab
    Abdel-Wahab
  3. Batlevi
    Batlevi
  4. Bernal
    Bernal
  5. Brentjens
    Brentjens
  6. Carter
    Carter
  7. Coit
    Coit
  8. Curran
    Curran
  9. Divgi
    Divgi
  10. Dogan
    Dogan

Groups

  1. Adult Leukemia (4)
  2. Center for Hematologic Malignancies (4)
  3. Department of Medicine (4)
  4. GSK Faculty (4)
  5. Hematologic Malignancies, Division of (4)
  6. Lymphoma (4)
  7. Survivorship Research (4)
  8. Molecular Pharmacology and Chemistry Program Faculty (3)
  9. Sloan Kettering Institute Faculty (3)
  10. Hematologic Malignancies Research (2)
Search Within
  1. "Adult Leukemia"
  2. "Lymphoma"
  3. "Survivorship Research"
Formats
  1. Journal Article (2)
  2. Meeting Abstract (2)
Groups
  1. Adult Leukemia (4)
  2. Center for Hematologic Malignancies (4)
  3. Department of Medicine (4)
  4. GSK Faculty (4)
  5. Hematologic Malignancies, Division of (4)
  6. Lymphoma (4)

More Groups

People
  1. David Straus (2)
  2. Matthew Matasar (2)
  3. Ahmet Dogan (1)
  4. Andrew Zelenetz (1)
  5. Anthony Mato (1)
  6. Ariela Noy (1)

More People

Years
  1. 2020 (1)
  2. 2015 (1)
  3. 1993 (1)
  4. 1990 (1)
Publications
  1. Journal of Clinical Oncology (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Initial results of a multicenter, investigator initiated study of MRD driven time limited therapy with zanubrutinib, obinutuzumab, and venetoclax
    Meeting Abstract

    Soumerai, J. D.; Mato, A. R.; Carter, J.; Dogan, A.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; Abramson, J. S.; Batlevi, C. L.; Joffe, E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase I trial of 19-28z chimeric antigen receptor modified T cells (19-28z CAR-T) post-high dose therapy and autologous stem cell transplant (HDT-ASCT) for relapsed and refractory (rel/ref) aggressive B-cell non-Hodgkin lymphoma (B-NHL)
    Meeting Abstract

    Sauter, C. S.; Riviere, I.; Bernal, Y.; Wang, X. Y.; Purdon, T.; Yoo, S.; Moskowitz, C. H.; Giralt, S.; Matasar, M. J.; Curran, K. J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease
    Journal Article

    Yahalom, J.; Gulati, S. C.; Toia, M.; Maslak, P.; McCarron, E. G.; O'Brien, J. P.; Portlock, C. S.; Straus, D. J.; Phillips, J.; Fuks, Z.
    Journal of Clinical Oncology (1993)

    Fulltext@MSK | Save
  • A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: Effects of tumor burden and antigen expression
    Journal Article

    Scheinberg, D. A.; Straus, D. J.; Yeh, S. D.; Divgi, C.; Garin-Chesa, P.; Graham, M.; Pentlow, K.; Coit, D.; Oettgen, H. F.; Old, L. J.
    Journal of Clinical Oncology (1990)

    Fulltext@MSK | Save